{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:19:20Z","timestamp":1788477560976,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijbiomac.2024.139446","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:03:49Z","timestamp":1736035429000},"page":"139446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["BefA protein alleviates progression of non-alcoholic fatty liver disease by modulating the AMPK signaling pathway through the gut-liver axis"],"prefix":"10.1016","volume":"294","author":[{"given":"Jie","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifa","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingtao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.139446_bb0005","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wai-Sun","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0010","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0015","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-lancet liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0035","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0040","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/liv.15404","article-title":"Management of NAFLD in primary care settings","volume":"42","author":"Wong","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0050","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"David","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108560","article-title":"Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD","volume":"26","author":"Yue","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175322","article-title":"Novel dual PPAR\u03b1\/\u03b3 agonists protect against liver steatosis and improve insulin sensitivity while avoiding side effects","volume":"935","author":"Guru","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158805","article-title":"The effects of probiotics, prebiotics and synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): a systematic review","volume":"23","author":"Carpi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0085","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0090","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2221485","article-title":"Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated \u03b3\u03b4T17 cell and macrophage polarization","volume":"15","author":"Han","year":"2023","journal-title":"Gut Microb."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20145","article-title":"A conserved bacterial protein induces pancreatic beta cell expansion during zebrafish development","volume":"5","author":"Hill","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0100","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.cmet.2022.09.001","article-title":"Guillemin, BefA, a microbiota-secreted membrane disrupter, disseminates to the pancreas and increases \u03b2 cell mass","volume":"34","author":"Hampton","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.719542","article-title":"Intestinal microbiota play an important role in the treatment of Type I diabetes in mice with BefA protein","volume":"11","author":"Qin","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0110","series-title":"Oral Administration of Bacterial \u03b2 Cell Expansion Factor A (BefA) Alleviates Diabetes in Mice with Type 1 and Type 2 Diabetes. Oxid Med Cell Longev","first-page":"9206039","author":"Wang","year":"2022"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0115","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Danyu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0120","first-page":"619","article-title":"Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World","volume":"11","author":"Vel\u00e1zquez","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0029665121003761","article-title":"Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism","volume":"81","author":"Nagarajan","year":"2021","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature14557","article-title":"The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1","volume":"524","author":"Han","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175457","article-title":"Gallic acid impairs fructose-driven de novo lipogenesis and ameliorates hepatic steatosis via AMPK-dependent suppression of SREBP-1\/ACC\/FASN cascade","volume":"940","author":"Lu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0140","article-title":"Dietary flaxseed oil prevents western-type diet-induced nonalcoholic fatty liver disease in apolipoprotein-e knockout mice","volume":"3256241","author":"Han","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0145","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0150","article-title":"Molecular mechanism of palmitic acid on myocardial contractility in hypertensive rats and its relationship with neural nitric oxide synthase protein in cardiomyocytes","volume":"6657476","author":"Tan","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12944-018-0933-z","article-title":"Concurrent exercise improves insulin resistance and nonalcoholic fatty liver disease by upregulating PPAR-\u03b3 and genes involved in the beta-oxidation of fatty acids in ApoE-KO mice fed a high-fat diet","volume":"18","author":"Zheng","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.nutres.2015.11.002","article-title":"Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease","volume":"36","author":"Kim","year":"2016","journal-title":"Nutr. Res."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/BST0340223","article-title":"Regulation of acetyl-CoA carboxylase","volume":"34","author":"Brownsey","year":"2006","journal-title":"Biochem. Soc. rans."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0170","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ijbiomac.2018.06.140","article-title":"Chicory (Cichorium intybus L.) polysaccharides attenuate high-fat diet induced non-alcoholic fatty liver disease via AMPK activation","volume":"118","author":"Yulong","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3390\/ijms21010360","article-title":"Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL\/6 mice model via AMPK\/Sirt1\/SREBP-1c\/PPAR\u03b3 pathway","volume":"21","author":"Chyau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0180","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1113643","article-title":"Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease","volume":"13","author":"Jin","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0190","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/biom9090435","article-title":"Raw bowl tea (Tuocha) polyphenol prevention of nonalcoholic fatty liver disease by regulating intestinal function in mice","volume":"9","author":"Liu","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108005","article-title":"Activation of a specific gut Bacteroides-folate-liver axis benefits for the alleviation of nonalcoholic hepatic steatosis","volume":"32","author":"Qiao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signaling in mice","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0205","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.2147\/DDDT.S379335","article-title":"Atorvastatin inhibits high-fat diet-induced lipid metabolism disorders in rats by inhibiting Bacteroides reduction and improving metabolism","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0210","first-page":"763","article-title":"Akkermansia muciniphila and Bifidobacterium bifidum prevent NAFLD by regulating FXR expression and gut microbiota","volume":"11","author":"Nian","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.ijbiomac.2024.139446_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/gutjnl-2020-322599","article-title":"Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide","volume":"71","author":"Lai","year":"2022","journal-title":"Gut"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024102577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024102577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:59:48Z","timestamp":1740358788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024102577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":43,"alternative-id":["S0141813024102577"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139446","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BefA protein alleviates progression of non-alcoholic fatty liver disease by modulating the AMPK signaling pathway through the gut-liver axis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"139446"}}